Who
Imran Nizamudin Alibhai
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Tvardi Therapeutics.
In numbers
- Trades disclosed
- 7
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 15 Apr 2025
- Last trade
- 29 Jan 2026
- Last filed
- 2 Feb 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 29 Jan 2026filed 2 Feb 2026 | TVRD Tvardi Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —115,000 at $0.00 | filing |
| 29 Jan 2026filed 2 Feb 2026 | TVRD Tvardi Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —115,000 at $0.00 | filing |
| 16 Dec 2025filed 18 Dec 2025 | TVRD Tvardi Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —47,500 at $0.00 | filing |
| 17 Apr 2025filed 21 Apr 2025 | TVRD Tvardi Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —182,320 at $0.00 | filing |
| 15 Apr 2025filed 17 Apr 2025 | TVRD Tvardi Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —207,881 | filing |
| 15 Apr 2025filed 17 Apr 2025 | TVRD Tvardi Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,011 | filing |
| 15 Apr 2025filed 17 Apr 2025 | TVRD Tvardi Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —160,940 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.